Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy

Clinical trial NCT02882477 · UNKNOWN

Trial details

NCT number: NCT02882477
Sponsor: Hadassah Medical Organization
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Iron Metabolism Disorders Gastroduodenal Ulcer Optic Atrophy Sensorineural Hearing Loss Platelet Dysfunction

Start date: 2016-12-01
Primary completion: 2018-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.